Xeljanz XR 11 MG tablet UU 30S
Ended Awarded
- Contract number
- SPE2DB26FWQWC
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $18,030
Award facts
- Contract value 100% obligated
- $18,030.07 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order awards AmerisourceBergen Drug Corp $18,030.07 for the supply of XELJANZ XR 11 mg tablets (30-count units) under a firm fixed price contract with the Defense Logistics Agency (DLA). The award, issued on November 4, 2025, represents a non-set-aside competitive procurement with performance completion targeted for November 5, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (contract SPE2DX), valued at $999,999,999.00 and extending through December 2026.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical supplier for federal military and veteran healthcare systems. The company maintains an extensive portfolio of pharmaceutical deliveries through the DLA Medical Supply Chain, providing brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. The SPE2DX prime vendor contract enables AmerisourceBergen to supply military healthcare programs globally while serving customers including the Defense Health Agency and U.S. Coast Guard, with the DLA Troop Support planning to establish next-generation Pharmaceutical Prime Vendor Global Program Generation V contracts across multiple regions.
Quick answers
Who was awarded contract SPE2DB26FWQWC?
SPE2DB26FWQWC was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 4, 2025.
How much is contract SPE2DB26FWQWC worth?
The government has obligated $18,030 on SPE2DB26FWQWC.
Is contract SPE2DB26FWQWC an order under another contract?
Yes. SPE2DB26FWQWC is a delivery order under SPE2DB25D3007, an indefinite delivery contract.
Was contract SPE2DB26FWQWC competed?
The extent of competition for SPE2DB26FWQWC was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award